Sacha Heppell of SmartTab Named by MM+M’s 40 Under 40 List As Medical Marketing Young Star
NEW YORK, NY – MM+M has announced its newest class of 40 Under 40 honorees. In its third year, the program shines a light on the young marketers whose leadership, strategic thinking and digital facility have contributed to the industry’s continued growth at a challenging time for the healthcare business as a whole.
Sacha Heppell is the Chief Marketing Officer of SmartTab, a revolutionary medtech startup that’s transforming wireless drug delivery.
He was the only Coloradan to make the MM+M 40 Under 40 list. SmartTab has quickly grown in recent years thanks to international partnerships and a grant from the Colorado Office of Economic Development and International Trade (OEDIT).
“It’s been a remarkable journey working and growing with SmartTab. We have accomplished so much in such a short period of time, but we are just getting warmed up. I feel honored by MM+M’s support for our work and am confident that SmartTab will continue our success to improve drug delivery for patients.” —Sacha Heppell, SmartTab CMO
The 40 Under 40 list includes individuals who hail from a range of employers, from pharma and biotech companies and agencies to device manufacturers, analytics firms and health media. At those organizations, the honorees hold a range of essential account, strategy and creative positions. With the world of medical marketing continuing to evolve in the digital era, these individuals inspire confidence that the industry is in good hands for the years ahead.
“It’s no secret that, within the broader marketing world, capable and enthusiastic young leaders are in high demand. This year’s 40 Under 40 honorees will show just how many of them have gravitated toward healthcare. As a result, the industry’s future is in good hands.” —MM+M editor-in-chief Larry Dobrow.
This year’s 40 Under 40 honorees hail from a range of the industry’s biggest and most well-respected organizations, including Meta, Fishawack Health, Johnson & Johnson, Weber Shandwick, & AstraZeneca.
The 2022 class of MM+M’s 40 Under 40 will be celebrated at a dinner to be held at The Edison Ballroom in New York City on March 24. For more information about MM+M’s 40 Under 40 program, visit www.mmm40under40.com.
Veloce Corporation (dba “SmartTab” or the “Company”) is currently engaged in the design, development and validation of next generation ingestible capsule drug delivery systems. Based in Denver, Colorado, it operates from their world-class innovation center for patient-centered delivery systems in various stages of clinical trials and FDA submission.
First published in 1966 as Medical Marketing and Media, MM+M is the media brand of record for pharmaceutical marketing and commercialization, delivering the most balanced and relevant coverage of the growing industry. The title produces an essential mix of online breaking news and analysis combined with monthly print features — timely, objective, original editorial content for an executive audience of leaders and thinkers who work in pharma, medical device, diagnostics and greater healthcare marketing. MM+M also develops conferences and live and virtual events, and engineers the industry’s premier awards program, the MM+M Awards.